فهرست و منابع تحقیق مقاله بیوسنتز کلسترول
فهرست:
معادله کلی مسیر بیوسنتز کلسترول.................................................................................................... 1
بیوسنتز کلسترول....................................................................................................................................... 2
بیوسنتز کلسترول- مرحله اول............................................................................................................... 2
بیوسنتز کلسترول- مرحله دوم.............................................................................................................. 4
بیوسنتز کلسترول- مرحله سوم............................................................................................................. 6
تنظیم بیوسنتز کلسترول......................................................................................................................... 7
SREBPS چیست؟.................................................................................................................................... 10
ناهنجاریهای مربوط به نقص در بیوسنتز کلسترول........................................................................... 11
- سندروم SLOS................................................................................................................................... 11
لاتواسترولوزیز...................................................................................................................................... 16
منابع............................................................................................................................................................... 23
منبع:
1997
Westfall D, Aboushadi N, Shackelford JE, Krisans SK. 1997. Metabolism of farnesol:
phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions.
Biochem Biophys Res Commun 230: 562-8.
Paton VG, Shackerford JE, Krisans SK. 1997. Cloning and subcellular localization of hamster and rat isopentenyl diphosphate dimethylallyl diphosphate isomerase. A
PTSI motif targets the enzyme to peroxisomes. J Biol Chem 272: 18945-50.
Engfelt WH, Shackelford JE, Aboushadi N, Jessani N, Masuda K. Paton VG, Keller GA, Krisans SK. 1997. Characterization of UT2 cells. The induction of peroxisomal 3-hydroxy-3- methylglutary - coenzyme a reductase. J Biol Chem 272: 24579-87.
1998
'Wanders RJ , Romeijn GJ. 1998. Differential deficiency of mevalonate kinase and
phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis:
evidence for a major role of peroxisomes in cholestrol biosynthesis. Biochem Biophys Res Commun 247 : 663-7.
Aboushadi N, Krisans SK. 1998. Analysis of isoprenoid biosynthesis in peroxisomal deficient Pex2- CHO cell lines. J Lipid Res 39: 1781- 91.
1999
Olivier LM, Chambliss KL, Gibson KM, Krisans SK. 1999. Characterization of phosphomevalonate kinase: chromosomal localization , regulation , and subcellular targeting. J Lipid Res 40 : 672- 9.
Aboushadi N, Engfelt WH, Paton VG, Krisans SK. 1999. Role of peroxisomes in isoprenoid biosynthesis. J Histochem Cytochem 47: 1127- 32.
Appelkvist EL, Venizelos N, Zhang Y, Parmryd I, Hagenfeldt L, Dallner G. 1999.
Synthesis of mevalonate pathway lipids in fibroblasts from Zellweger and X- linked ALD patients. Pediatr Res 46: 345-50.
2000
Aboushadi N, Shackleford JE, Jessani N, Gentile A, Krisans SK. 2000.
Characterization of peroxisomal 3-hydroxy- 3- methylglutary coenzyme A reductase in peroxisomes: stero biosynthesis , phosphyorylation , degraation , and stain inhibition. Biochemistry 39: 237- 47.
Tint , G. S. , Irons, M., Elias , E. R., Batta, A. K., Frieden , R., Chen, T.S. and Salen, G. (1994) Defective cholesterol biosynthesis associated with the Smith- Lemli- Opitz syndrome. New Engl. J. Med., 330, 107- 113. [Abstract/ Free Full Text]
Kelley , R.I. (2000) Inborn errors of cholesterol biosynthesis. Adv. Pediatr., 47, 1-53. [Medline]
Kelley, R. I. and Herman, G. E. (2001) Inborn errors of cholesterol biosynthesis. A. Rev. Genomics Hum. Genet., 2, 299- 341. [CrossRef][ISI]
Opitz, J.M., Gilbert- Barness, E., Ackerman, J. and Lowichik , a. (2002) Cholesterol and development : the RSH ('Smith - Lemli- Opitz') syndrome and related conditions. Pediatr. Pathol. Mol. Med., 21, 153- 181. [Crossref][ISI][Medline]
Waterham, H.R., Koster, J., Mooyer, P., Noort Gv, G., Kelley, R.I., Wilcox, W.R. Wanders, R.j., Hennekam , R.C. and Oosterwijk , J.C. (2003) Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am. J. Hum. Genet., 72, 1013-1017 [CrossRef][ISI][Medline]
Nowaczyk, M. J., McCaughey, D., Whelan, D.T. and Porter, F. D. (2001) Incidence of Smith - Lemli- Opitz syndrome in Ontario , Canada. Am. J. Med. Genet., 102, 18-20. [CrossRef][ISI][Medline]
Wassif, C. A., Zhu, P., Kratz, L., Krakowiak, P.A., Battaile, K.P., Weight, F.F.Grinberg, A., Steiner, R.D., Nwokoro, N.A., Kelley, R.I. et al. (2001) Biochemical , phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith - Lemli- Opitz syndrome. Hum. Mol. Genet., 10, 555-564. [Abstract/Free Full Text]
Parnes, S., Hunter, A.G., Jimenez, C., Carpenter, B.F. and MacDonald, I. (1990) Apparent Smith- Lemli- Opitz syndrome in a child with a previously undescribed form of mucolipidosis not involving the neurons. Am. J. Med. Genel., 35,397-405. [ISI][Medline]